In line with this, lithium, a GSK3β inhibitor and autophagy inducer, confers neuroprotection by reducing the burden of Aβ plaques as well as p-Aβ and p-tau in a variety of AD animal models [166,167,168,169]. The gene discussed is MAPT; the disease is Alzheimer disease.